Related Experiment Video

Updated: Jul 15, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

Doxazosin: a study in a cohort of patients with hypertension in general practice--an interim report

C G Langdon1

  • 1Symons Medical Centre, Berkshire, England.

American Heart Journal
|January 1, 1991
PubMed

Insights

Doxazosin effectively lowered blood pressure and improved cholesterol levels in hypertensive patients. This alpha-blocker demonstrated a significant reduction in coronary heart disease risk, enhancing cardiovascular health.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertension is a prevalent condition requiring effective management.
  • Many hypertensive patients have dyslipidemia, increasing cardiovascular risk.

Purpose of the Study:

  • To evaluate the safety and efficacy of doxazosin in a large cohort of general practice hypertensive patients.
  • To assess the impact of doxazosin on blood pressure, heart rate, and lipid profiles.

Main Methods:

  • A cohort of 4027 hypertensive patients was studied.
  • Patients received doxazosin therapy, with blood pressure and lipid levels monitored.
  • Adverse events and treatment discontinuations were recorded.

Main Results:

  • Doxazosin reduced mean blood pressure by 22/15 mm Hg and heart rate by 1 beat/min.
  • Treatment discontinuation due to adverse events occurred in 5.8% of patients.
  • Significant improvements were observed in total cholesterol, LDL, triglycerides, HDL, and HDL:total cholesterol ratio, potentially reducing 10-year CHD risk by 20.4%.

Conclusions:

  • Doxazosin is a safe and effective treatment for hypertension, offering significant cardiovascular benefits beyond blood pressure control.
  • The drug positively impacts lipid profiles, contributing to a reduced risk of coronary heart disease.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...